Ulrik Kihlbom
Professor
E-mail: ulrik.kihlbom@ki.se
Telephone: +46852483653
Mobile phone: +46705156040
Visiting address: Widerströmska huset, Tomtebodavägen 18A, 17165 Solna
Postal address: C7 Lärande, Informatik, Management och Etik, C7 Etik Helgesson, 171 77 Stockholm
About me
- I am Professor of Medical Clinical Ethics in the Stockholm Centre for Healthcare Ethics, Department of Learning, Informatics, Management and Ethics (LIME), KI.
My primary research interests include ethical issues related to patients’ perspective and decision-making, the ethics of social care and public health, normative ethics and methodology of bioethics. Currently I am leading a group that addresses patients’ views and the ethics of precision medicine in hematology within a European consortia (the 3-year project MEET-AML, funded by ERAPerMed. I am also doing the ethics part in another ERAPerMed funded project, RELIABLE, in which we assess personalized preventive strategies for patients in the early stages of Multiple Sclerosis (MS).
From 2024, I am the principal investigator of the interdisciplinary project "In the best interest of the child? Ethical, legal and empirical assessments of decisions in social service to restrict social contact", funden by the Swedish Research Council (2024-2026) and with researchers from philosophy, public health, law and social work.
I teach at various courses on ethical issues at KI as well as for health care professionals in various disciplines.
I am a member of the Ethics Council of Karolinska University Hospital, the Ethics council of Astrid Lindgren Children's Hospital, and the Scientific Advisory Committee for the Swedish Agency for Health Technology Assessment and Assessment of Social Services (SBU).
Articles
-
Article: PATIENT EDUCATION AND COUNSELING. 2023;115:107883
-
Article: FRONTIERS IN PHARMACOLOGY. 2023;14:1192770
-
Journal article: INTERNATIONAL JOURNAL OF QUALITATIVE STUDIES ON HEALTH AND WELL-BEING. 2022;17(1):2103137
-
Journal article: PATIENT EDUCATION AND COUNSELING. 2021;104(10):2577-2585
-
Journal article: BMJ OPEN. 2021;11(4):e045851
-
Article: SCHIZOPHRENIA RESEARCH. 2021;228:360-366
-
Journal article: PATIENT PREFERENCE AND ADHERENCE. 2021;15:1331-1345
-
Journal article: ARTHRITIS RESEARCH & THERAPY. 2020;22(1):288
-
Journal article: JOURNAL OF BIOETHICAL INQUIRY. 2020;17(4):749-755
-
Journal article: BMC MEDICAL ETHICS. 2020;21(1):30
-
Journal article: PATIENT-PATIENT CENTERED OUTCOMES RESEARCH. 2019;12(3):297-305
-
Journal article: VALUE IN HEALTH. 2019;22(4):491-501
-
Journal article: PATIENT PREFERENCE AND ADHERENCE. 2019;13:273-282
-
Journal article: JOURNAL OF RISK RESEARCH. 2018;21(2):222-235
-
Journal article: PROGRESS IN NUCLEIC ACID RESEARCH AND MOLECULAR BIOLOGY. 2018;158:299-323
-
Journal article: JOURNAL OF ONCOLOGY PRACTICE. 2017;13(10):679-682
-
Journal article: VALUE IN HEALTH. 2017;20(9):A540
-
Journal article: UPSALA JOURNAL OF MEDICAL SCIENCES. 2016;121(4):295-298
-
Journal article: UPSALA JOURNAL OF MEDICAL SCIENCES. 2016;121(4):289-294
-
Journal article: EUROPEAN JOURNAL OF CANCER CARE. 2016;25(3):516-523
-
Journal article: JOURNAL OF MEDICAL ETHICS. 2015;41(2):183-185
-
Journal article: EUROPEAN JOURNAL OF CANCER CARE. 2015;24(1):133-141
-
Journal article: SUPPORTIVE CARE IN CANCER. 2013;21(11):3137-3142
-
Journal article: PHYSICAL CULTURE AND SPORT, STUDIES AND RESEARCH. 2013;59(1):21-32
-
Journal article: SPORT, ETHICS AND PHILOSOPHY. 2012;6(4):467-479
-
Journal article: SPORT, ETHICS AND PHILOSOPHY. 2011;5(2):149-160
-
Journal article: ACTA PAEDIATRICA. 2009;98(8):1349-1354
-
Journal article: JOURNAL OF MEDICAL ETHICS. 2008;34(3):146-149
-
Journal article: BMC MEDICAL ETHICS. 2007;8:6
-
Journal article: BIOETHICS. 2000;14(4):287-309
- Show more
All other publications
-
Book chapter: 2021;p.Ethical Aspects of Regulating Oncology Products
-
Book chapter: 2020;p.Introduction
-
Book chapter: 2020;p."They don't really understand"
-
Book: 2020Ethical, Social and Psychological Impacts of Genomic Risk Communication
-
Book chapter: 2020;p.Epilogue
-
Book chapter: 2019;p.Healthcare Decisions
Grants
-
Swedish Research Council1 January 2024 - 31 December 2026
-
RELIABLE (Targeting subclinical motor and cognitive impairment in patients with early onset Multiple Sclerosis at high Risk of disEase acitivity through a preventive personaLised and InnovAtive rehaBiLitation stratEgy)ERA PerMed/Vinnova1 March 2022 - 28 February 2025
-
Swedish Research Council1 January 2021 - 31 December 2022
-
Swedish Research Council1 January 2020 - 31 December 2022
-
Innovative Medicines Initiative (IMI) 21 October 2016 - 31 May 2022